ClinicalTrials.gov
ClinicalTrials.gov Menu

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01566747
Recruitment Status : Active, not recruiting
First Posted : March 29, 2012
Last Update Posted : May 31, 2017
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Cancer Trials Ireland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : August 13, 2015
  Study Completion Date : No date given